학술논문

Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial.
Document Type
Journal Article
Source
Lancet. 6/16/2012, Vol. 379 Issue 9833, p2270-2278. 9p.
Subject
Language
ISSN
0140-6736